Société Karolinska Development AB London S.E.
Actions
0P3C
SE0002190926
Equipement, fournitures et distribution médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,403 SEK | +48,79% |
|
+55,67% | +42,47% |
28/05 | Karolinska Development vise une participation de 10% dans Boost Pharma | MT |
16/05 | Karolinska Development AB (Publ) nomme Hans Wigzell au poste d'administrateur et de président | CI |
Métier
Nombre d'employés: 8
Ventes par activité
SEK en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12,43% |
Ventes par région
SEK en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12,43% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07/12/15 |
Director of Finance/CFO | 56 | 01/10/22 | |
John Öhd
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/06/20 |
Chief Investment Officer | 58 | 01/03/21 | |
Linda Spahiu
PRN | Corporate Officer/Principal | 39 | - |
Johan Dighed
LAW | General Counsel | 51 | 01/05/20 |
Corporate Officer/Principal | 59 | 01/11/15 | |
Eva Montgomerie
AUD | Comptroller/Controller/Auditor | 66 | 01/01/07 |
Thomas Andersson
PRN | Corporate Officer/Principal | 72 | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07/12/15 |
Director/Board Member | 55 | 19/02/21 | |
Benjamin Toogood
BRD | Director/Board Member | 48 | 19/02/21 |
Theresa Tse
BRD | Director/Board Member | 32 | 28/11/17 |
Philip Duong
BRD | Director/Board Member | 34 | 12/01/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 10 | 2 555 261 | 0 | 0 | 35,19 % |
Action B | 1 | 267 522 333 | 95 049 884 ( 35,53 %) | 244 285 ( 0,0913 %) |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
OSSDSIGN AB 9,83% | 9 596 662 | 9,83% | 8 427 501 $ |
Coordonnées société
Karolinska Development AB
Tomtebodavägen 23 A
171 65, Solna
+46 8 524 860 70
http://www.karolinskadevelopment.com![Adresse Karolinska Development AB(0P3C)](https://cdn.zonebourse.com/static/address/9276560.png)
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
KDev Investments AB
![]() KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. |
Biotechnology
|
Secteur
Révisions de BNA
Bénéfices annuels - Taux de surprise
Varia. 1 janv. | Capi. | |
---|---|---|
-6,68% | 179 Md | |
-5,20% | 98,84 Md | |
-5,38% | 65,34 Md | |
+15,46% | 45,41 Md | |
-6,47% | 44,94 Md | |
+9,74% | 43,76 Md | |
+14,01% | 29,01 Md | |
+19,39% | 25,65 Md | |
-6,53% | 23,32 Md |
- Bourse
- Actions
- Action KDEV
- Action 0P3C
- Société Karolinska Development AB